Angenendt, Linus <br/><br/>
Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease.  [electronic resource] 

 -  Annals of hematology  Jul 2015 
 - 1241-3 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-015-2353-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Castleman Disease--diagnosis<br/>Humans<br/>Male<br/>Remission Induction<br/>Rituximab<br/>Severity of Illness Index<br/>Stem Cell Transplantation--trends<br/>Transplantation, Homologous--trends